Evidence map›Paper›PMID 31222168›Full record

ArticleScientific reports2019

Proteomic profiling of extracellular vesicles reveals additional diagnostic biomarkers for myocardial infarction compared to plasma alone.

Olof Gidlöf, Mikael Evander, Melinda Rezeli, György Marko-Varga, Thomas Laurell, David Erlinge

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 78 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Diagnostic and prognostic significance of circulating extracellular vesicles in gastrointestinal cancers.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  9. Review
  10. Article
  11. Article
  12. Development of surface-functionalized power-free microchip for breast cancer cell-derived extracellular vesicle detection.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2026
    Article
  13. Review
  14. Review
  15. Article
  16. Plasma-Derived Extracellular Vesicle Proteomics.Journal of proteome research · 2025
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Olof GidlöfDepartment of Cardiology, Clinical Sciences, Lund University, PO Box 118, 221 00, Lund, Sweden. olof.gidlof@med.lu.se.ORCID http://orcid.org/0000-0002-7402-3139
Mikael EvanderDepartment of Biomedical Engineering, Lund University, PO Box 118, 221 00, Lund, Sweden.
Melinda RezeliDepartment of Biomedical Engineering, Lund University, PO Box 118, 221 00, Lund, Sweden.
György Marko-VargaDepartment of Biomedical Engineering, Lund University, PO Box 118, 221 00, Lund, Sweden.
Thomas LaurellDepartment of Biomedical Engineering, Lund University, PO Box 118, 221 00, Lund, Sweden.
David ErlingeDepartment of Cardiology, Clinical Sciences, Lund University, PO Box 118, 221 00, Lund, Sweden.
Lund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vesicles (EVs) are submicron, membrane-enclosed particles that are released from cells in various pathophysiological states. The molecular cargo of these vesicles is considered to reflect the composition of the cell of origin, and the EV proteome is therefore a potential source of biomarkers for various diseases. Our aim was to determine whether EVs isolated from plasma provide additional diagnostic value or improved pathophysiological understanding compared to plasma alone in the context of myocardial infarction (MI). A panel of proximity extension assays (n = 92) was employed to analyze EV lysates and plasma from patients with MI (n = 60) and healthy controls (n = 22). After adjustment for multiple comparisons, a total of 11 dysregulated proteins were identified in EVs of MI patients compared to the controls (q < 0.01). Three of these proteins: chymotrypsin C (CTRC), proto-oncogene tyrosine-protein kinase SRC (SRC) and C-C motif chemokine ligand 17 (CCL17) were unaltered in the corresponding plasma samples. As biomarkers for MI, rudimentary to no evidence exists for these proteins. In a separate group of patients with varying degrees of coronary artery disease, the decrease in EV-associated (but not plasma-related) SRC levels was confirmed by ELISA. Confirmation of the presence of SRC on EVs of different sizes and cellular origins was performed with ELISA, flow cytometry and nanoparticle tracking analysis. In conclusion, the data revealed that despite a similarity in the EV and plasma proteomes, analysis of isolated EVs does indeed provide additional diagnostic information that cannot be obtained from plasma alone.

Indexed as

BiomarkersProteomeProteomicsAgedChromatography, LiquidComputational BiologyEnzyme-Linked Immunosorbent AssayExtracellular VesiclesFemaleFlow CytometryHumansMaleMiddle AgedMyocardial InfarctionProto-Oncogene MasReproducibility of ResultsBiomarkersMAS1 protein, humanProteomeProto-Oncogene Mas

Identifiers

PMID31222168
PMCPMC6586849
OpenAlexW2950773679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.